Physician's Weekly
JUNE 13, 2025
Many of us are taught in medical school and residency the importance of patient communication on improving patient satisfaction scores, quality metrics, and professional fulfillment. There is robust data regarding the importance of patient connection and engagement in the hospital and clinic setting.
Physician's Weekly
JUNE 26, 2025
For physicians, nurses, medical assistants, and support staff, workplace violence (WPV) is now a daily hazard, inflicting physical injury, emotional trauma, and eroding the quality of patient care. Current Responses: Necessary but Insufficient Medical organizations have responded with advocacy efforts and public campaigns.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
My Green Doctor
APRIL 4, 2025
New Research: Teaching Patients about Climate Resilience Newly published original research co-authored by My Green Doctor’s Dr. Todd Sack concludes that, “ the medical office waiting room appears to be an accepted, time-efficient, and effective site to communicate knowledge on climate change and health. ” Contact us today! of total U.S.
LEAD Physician
SEPTEMBER 26, 2022
Physicians must be leaders in their field to provide excellent patient care, manage a large team and coordinate between departments, and support their patient's overall health with information about prevention and maintenance. How can a physician lead their field? Physicians must constantly shift gears from one situation to another.
FDA Law Blog
JULY 10, 2024
Lenz, Principal Medical Device Regulation Expert — FDA’s Center for Devices and Radiological Health (CDRH) recently partnered with the Digital Medicine Society (DiMe) to host a two-day workshop to help advance the use of patient-generated health data (PGHD) to support improved clinical trials, medical device development, and regulatory science.
FDA Law Blog
JULY 17, 2024
As originally proposed, this new Committee could be convened in conjunction with the existing medical specialty area-focused advisory committees, akin to the Drug Safety and Risk Management Advisory Committee. those reviewed by the CDER Division of Rare Diseases and Medical Genetics).
FDA Law Blog
SEPTEMBER 20, 2021
FDA will discuss the goals letter and field public comments, on September 28, 2021 (announcement here ), as well as a separate workshop on meetings management practices, which is to be held by July 30, 2024. The Agency will hold as many as three public workshops during PDUFA VII related to rare disease endpoint development.
Expert insights. Personalized for you.
52 
Let's personalize your content